Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review

References

• Who. Obesity And Overweight. 2021.
   Google Scholar
• Nightingale H, Mnatzaganian G, Hooker L, et al. The effect of motivational interviewing and/or cognitive behaviour therapy techniques on gestational weight gain – a systematic review and meta-analysis. BMC Public Health. 2023;23(1):626. doi: 10.1186/s12889-023-15446-9
   PubMed Web of Science ®Google Scholar
• Rogozińska E, Zamora J, Marlin N, et al. Gestational weight gain outside the institute of medicine recommendations and adverse pregnancy outcomes: analysis using individual participant data from randomised trials. Bmc Pregnancy Childbirth. 2019;19(1):322. doi: 10.1186/s12884-019-2472-7
   PubMed Web of Science ®Google Scholar
• Rasmussen KM, Yaktine AL. Institute of M, National Research Council Committee to Reexamine IOMPWG. The National Academies Collection: Reports funded by National Institutes of Health. Weight Gain During Pregnancy: Reexamining the Guidelines. 2009. p. 2–3.
   Google Scholar
• Chen C, Xu X, Yan Y, et al. Estimated global overweight and obesity burden in pregnant women based on panel data model. PLoS One. 2018;13(8):e0202183. doi: 10.1371/journal.pone.0202183
   PubMed Web of Science ®Google Scholar
• Goldstein RF, Abell SK, Ranasinha S, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA. 2017 Jun 6;317(21):2207–2225. doi: 10.1001/jama.2017.3635
   PubMed Web of Science ®Google Scholar
• Kominiarek M, Saade G, Mele L, et al. Association between gestational weight gain and perinatal outcomes. Obstet & GynecolObstetrics And Gynecology (New York 1953). 2018;132(4):875–881. doi: 10.1097/AOG.0000000000002854
   PubMed Web of Science ®Google Scholar
• Najafi F, Hasani J, Izadi N, et al. The effect of prepregnancy body mass index on the risk of gestational diabetes mellitus: a systematic review and dose‐response meta‐analysis. Obesity Rev. 2019;20(3):472–486. doi: 10.1111/obr.12803
   PubMed Web of Science ®Google Scholar
• Carrasco-Wong I, Moller A, Giachini FR, et al. Placental structure in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis. 2020 Feb 1;1866(2):165535. doi: 10.1016/j.bbadis.2019.165535
   PubMed Web of Science ®Google Scholar
• Moradi Y. The relationship between body mass index and preeclampsia: a systematic review and meta-analysis. Int J Reprod Biomed (Yazd). 2022;20(12):1051–1052. doi: 10.18502/ijrm.v20i12.12568
   PubMed Web of Science ®Google Scholar
• He X-J, Dai R-X, Hu C-L. Maternal prepregnancy overweight and obesity and the risk of preeclampsia: a meta-analysis of cohort studies. Obes Research & Clinical Practice. 2020;14(1):27–33. doi: 10.1016/j.orcp.2020.01.004
   PubMed Web of Science ®Google Scholar
• Torloni MR, Betrán AP, Daher S, et al. Maternal BMI and preterm birth: a systematic review of the literature with meta-analysis. J Matern-Fetal Neonatal Med. 2009;22(11):957–970. doi: 10.3109/14767050903042561
   PubMed Web of Science ®Google Scholar
• Liu L, Ma Y, Wang N, et al. Maternal body mass index and risk of neonatal adverse outcomes in China: a systematic review and meta-analysis. Bmc Pregnancy Childbirth. 2019;19(1):105. doi: 10.1186/s12884-019-2249-z
   PubMed Web of Science ®Google Scholar
• Saadia Z. Association between maternal obesity and cesarean delivery complications. Cureus. 2020;12(3):e7163. doi: 10.7759/cureus.7163
   PubMed Web of Science ®Google Scholar
• Chu SY, Kim SY, Schmid CH, et al. Maternal obesity and risk of cesarean delivery: a meta-analysis. Obesity Rev. 2007;8(5):385–394. doi: 10.1111/j.1467-789X.2007.00397.x
   PubMed Web of Science ®Google Scholar
• Castaneda C, Marsden K, Maxwell T, et al. Prevalence of maternal obesity at delivery and association with maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2022 Dec;35(25):8544–8551. doi: 10.1080/14767058.2021.1988563
   PubMed Web of Science ®Google Scholar
• Metsälä J, Stach-Lempinen B, Gissler M, et al. Risk of pregnancy complications in relation to maternal prepregnancy body mass index: population-based study from Finland 2006-10. Paediatric Perinatal Epidemiol. 2016 Jan;30(1):28–37. doi: 10.1111/ppe.12248
   PubMed Web of Science ®Google Scholar
• Scheidl TB, Brightwell AL, Easson SH, et al. Maternal obesity and programming of metabolic syndrome in the offspring: searching for mechanisms in the adipocyte progenitor pool. BMC Med. 2023 Feb 13;21(1):50. doi: 10.1186/s12916-023-02730-z
   PubMed Web of Science ®Google Scholar
• Dodd JM, Deussen AR, Mitchell M, et al. Maternal overweight and obesity during pregnancy: strategies to improve outcomes for women, babies, and children. Expert Rev Endocrinol Metab. 2022 Jul;17(4):343–349. doi: 10.1080/17446651.2022.2094366
   PubMed Web of Science ®Google Scholar
• Matuszak O, Banach W, Pogorzały B, et al. The long-term effect of maternal obesity on the cardiovascular health of the offspring-systematic review. Curr Probl Cardiol. 2024 Jan;49(1 Pt B):102062. doi: 10.1016/j.cpcardiol.2023.102062
   PubMed Web of Science ®Google Scholar
• Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023 Dec;79(6):1542–1556. doi: 10.1016/j.jhep.2023.06.003
   PubMed Web of Science ®Google Scholar
• Chan KE, Koh TJL, Tang ASP, et al. Global prevalence and clinical characteristics of metabolic associated fatty liver disease. A meta-analysis and systematic review of 10,739,607 individuals. JClinEndocrinolmetab. 2022;107(9):2691–2700. doi: 10.1210/clinem/dgac321
   PubMed Web of Science ®Google Scholar
• Murag S, Ahmed A, Kim D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver. 2021 Mar 15;15(2):206–216. doi: 10.5009/gnl20127
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease – meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi: 10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Azzaroli F, Mazzella G, Marchesini G, et al. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expert Rev Gastroenterol Hepatol. 2020 Feb;14(2):127–135. doi: 10.1080/17474124.2020.1715210
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease – a global public health perspective. J Hepatol. 2019;70(3):531–544. doi: 10.1016/j.jhep.2018.10.033
   PubMed Web of Science ®Google Scholar
• Kubihal S, Gupta Y, Shalimar, et al. Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. J Of Diabetes Invest. 2021 May;12(5):877–885. doi: 10.1111/jdi.13411
   PubMed Web of Science ®Google Scholar
• Mazzotti A, Caletti MT, Sasdelli AS, et al. Pathophysiology of nonalcoholic fatty liver disease: lifestyle-gut-gene interaction. Dig Dis. 2016;34(Suppl 1):3–10. doi: 10.1159/000447275
   PubMed Web of Science ®Google Scholar
• Sarkar M, Grab J, Dodge JL, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020 Sep;73(3):516–522. doi: 10.1016/j.jhep.2020.03.049
   PubMed Web of Science ®Google Scholar
• Poon LC, McIntyre HD, Hyett JA, et al. The first-trimester of pregnancy – a window of opportunity for prediction and prevention of pregnancy complications and future life. Diabetes Res Clin Pract. 2018;145:20–30. doi: 10.1016/j.diabres.2018.05.002
   PubMed Web of Science ®Google Scholar
• Parrettini S, Caroli A, Torlone E. Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and gestational diabetes. Front Endocrinol. 2020;11:611929. doi: 10.3389/fendo.2020.611929
   PubMed Web of Science ®Google Scholar
• Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000 May;71(5 Suppl):1256s–1261s. doi: 10.1093/ajcn/71.5.1256s
   PubMed Web of Science ®Google Scholar
• Armistead B, Johnson E, VanderKamp R, et al. Placental regulation of energy homeostasis during human pregnancy. Endocrinology. 2020 Jul 1;161(7). doi: 10.1210/endocr/bqaa076
   PubMed Web of Science ®Google Scholar
• Lain K, Catalano P. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50(4):938–948. doi: 10.1097/GRF.0b013e31815a5494
   PubMed Web of Science ®Google Scholar
• Zeng Z, Liu F, Li S. Metabolic adaptations in pregnancy. Ann Nutr Metab. 2017;70(1):59–65. doi: 10.1159/000459633
   PubMed Web of Science ®Google Scholar
• Kampmann U, Knorr S, Fuglsang J, et al. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156. doi: 10.1155/2019/5320156
   PubMed Web of Science ®Google Scholar
• Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365–371. doi: 10.1530/REP-10-0088
   PubMed Web of Science ®Google Scholar
• Kalhan S, Rossi K, Gruca L, et al. Glucose turnover and gluconeogenesis in human pregnancy. J Clin Investig. 1997;100(7):1775–1781. doi: 10.1172/JCI119704
   PubMed Web of Science ®Google Scholar
• Herrera E, Ortega-Senovilla H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol. 2014;15(1):24–31. doi: 10.2174/1389201015666140330192345
   PubMed Web of Science ®Google Scholar
• Catalano PM, Tyzbir ED, Wolfe RR, et al. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol. 1992;167(4):913–919. doi: 10.1016/S0002-9378(12)80011-1
   PubMed Web of Science ®Google Scholar
• Kelly AC, Powell TL, Jansson T. Placental function in maternal obesity. Clin Sci (Lond). 2020 Apr 30;134(8):961–984. doi: 10.1042/CS20190266
   PubMed Web of Science ®Google Scholar
• Maltepe E, Fisher SJ. Placenta: the forgotten organ. Annu Rev Cell Dev Biol. 2015;31(1):523–552. doi: 10.1146/annurev-cellbio-100814-125620
   PubMedGoogle Scholar
• Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):409–416. doi: 10.1097/MED.0b013e32834c800d
   PubMed Web of Science ®Google Scholar
• Cowett RM, Farrag HM. Selected principles of perinatal–neonatal glucose metabolism. Netherlands: Operating Company Elsevier Ltd; 2004. p. 37–47.
   Google Scholar
• Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19(1):13–22. doi: 10.1385/ENDO:19:1:13
   PubMed Web of Science ®Google Scholar
• Illsley NP, Baumann MU. Human placental glucose transport in fetoplacental growth and metabolism. Biochimica et biophysica acta molecular basis of disease. Biochim Biophys Acta (BBA) – Mol Basis Dis. 2020;1866(2):165359. doi: 10.1016/j.bbadis.2018.12.010
   PubMed Web of Science ®Google Scholar
• Sibiak R, Jankowski M, Gutaj P, et al. Placental lactogen as a marker of maternal obesity, diabetes, and fetal growth abnormalities: current knowledge and clinical perspectives. J Clin Med. 2020 Apr 16;9(4):1142. doi: 10.3390/jcm9041142
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kubota N, Yamauchi T, et al. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156
   PubMed Web of Science ®Google Scholar
• Pantham P, Aye IL, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015 Jul;36(7):709–715. doi: 10.1016/j.placenta.2015.04.006
   PubMed Web of Science ®Google Scholar
• Kyrou I, Randeva HS, Tsigos C, et al. Clinical problems caused by obesity. In: Feingold K, Anawalt B, Blackman M, et al., Eds. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright © 2000–2023, MDText.com, Inc.; 2000.
   Google Scholar
• Francisco V, Sanz MJ, Real JT, et al. Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets? Biology (Basel). 2022 Aug 19;11(8):1237. doi: 10.3390/biology11081237
   PubMedGoogle Scholar
• Jiménez-Cortegana C, García-Galey A, Tami M, et al. Role of leptin in non-alcoholic fatty liver disease. Biomedicines. 2021;9(7):762. doi: 10.3390/biomedicines9070762
   PubMed Web of Science ®Google Scholar
• Flessa CM, Nasiri-Ansari N, Kyrou I, et al. Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research. Int J Mol Sci. 2022 Dec 13;23(24):15791. doi: 10.3390/ijms232415791
   PubMed Web of Science ®Google Scholar
• Valenti L, Bugianesi E, Pajvani U, et al. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int. 2016;36(11):1563–1579. doi: 10.1111/liv.13185
   PubMed Web of Science ®Google Scholar
• Fouda S, Vennikandam MM, Pappachan JM, et al. Pregnancy and metabolic-associated fatty liver disease: a clinical update. J Clin Transl Hepatol. 2022;10(5):947–954. doi: 10.14218/JCTH.2022.00052
   PubMed Web of Science ®Google Scholar
• Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Cells. 2019;8(10):1259. doi: 10.3390/cells8101259
   PubMed Web of Science ®Google Scholar
• Flessa CM, Kyrou I, Nasiri-Ansari N, et al. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD). J Cell Biochem. 2022 Oct;123(10):1585–1606. doi: 10.1002/jcb.30247
   PubMed Web of Science ®Google Scholar
• Flessa CM, Kyrou I, Nasiri-Ansari N, et al. Endoplasmic reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives. Curr Obes Rep. 2021 Jun;10(2):134–161. doi: 10.1007/s13679-021-00431-3
   PubMed Web of Science ®Google Scholar
• Kim TH, Hong D-G, Yang YM. Hepatokines and non-alcoholic fatty liver disease: linking liver pathophysiology to metabolism. Biomedicines. 2021;9(12):1903. doi: 10.3390/biomedicines9121903
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk AA, Zheng D, Shibolet O, et al. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019 Feb;11(2). doi: 10.15252/emmm.201809302
   PubMed Web of Science ®Google Scholar
• Wang JS, Liu JC. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World J Clin Cases. 2022 Nov 6;10(31):11240–11251. doi: 10.12998/wjcc.v10.i31.11240
   PubMed Web of Science ®Google Scholar
• Kim JC, Jeon JY, Yang WS, et al. Combined amelioration of ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and probiotic lactobacillus on non-alcoholic fatty liver disease. Curr Pharm Biotechnol. 2019;20(3):222–231. doi: 10.2174/1389201020666190311143554
   PubMed Web of Science ®Google Scholar
• Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol. 2005 Jul;39(6):540–543. doi: 10.1097/01.mcg.0000165671.25272.0f
   PubMed Web of Science ®Google Scholar
• Liu L, Li P, Liu Y, et al. Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis. Dig Dis Sci. 2019 Dec;64(12):3402–3412. doi: 10.1007/s10620-019-05699-z
   PubMed Web of Science ®Google Scholar
• Yin X, Guo X, Liu Z, et al. Advances in the diagnosis and treatment of non-alcoholic fatty liver disease. Int J Mol Sci. 2023 Feb 2;24(3):2844. doi: 10.3390/ijms24032844
   PubMed Web of Science ®Google Scholar
• Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts. Curr Pharm Des. 2018;24(38):4574–4586. doi: 10.2174/1381612825666190117102111
   PubMed Web of Science ®Google Scholar
• Henry L, Eberly KE, Shah D, et al. Noninvasive tests used in risk stratification of patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2023 May;27(2):373–395. doi: 10.1016/j.cld.2023.01.022
   PubMed Web of Science ®Google Scholar
• Staufer K, Halilbasic E, Spindelboeck W, et al. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United Eur Gastroenterol J. 2019 Oct;7(8):1113–1123. doi: 10.1177/2050640619865133
   PubMed Web of Science ®Google Scholar
• Kechagias S, Ekstedt M, Simonsson C, et al. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones (Athens). 2022 Sep;21(3):349–368. doi: 10.1007/s42000-022-00377-8
   PubMedGoogle Scholar
• Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005 Sep 8;5(1):26. doi: 10.1186/1471-2261-5-26
   PubMedGoogle Scholar
• Kyrou I, Panagiotakos DB, Kouli GM, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: the ATTICA study. Atherosclerosis. 2018 Dec;279:10–16. doi: 10.1016/j.atherosclerosis.2018.10.015
   PubMed Web of Science ®Google Scholar
• Ebrahimi M, Seyedi SA, Nabipoorashrafi SA, et al. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Lipids Health Dis. 2023 Mar 15;22(1):41. doi: 10.1186/s12944-023-01802-6
   PubMed Web of Science ®Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6(1):33. doi: 10.1186/1471-230X-6-33
   PubMed Web of Science ®Google Scholar
• Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterol. 2009 Sep;137(3):865–872. doi: 10.1053/j.gastro.2009.06.005
   PubMed Web of Science ®Google Scholar
• Koralegedara IS, Warnasekara JN, Rathnayake A, et al. Fatty liver index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy. BMJ Open Gastroenterol. 2022 Jun;9(1):e000913. doi: 10.1136/bmjgast-2022-000913
   PubMed Web of Science ®Google Scholar
• Bannaga AS, Metzger J, Kyrou I, et al. Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis-A multicentre study. EBioMedicine. 2020 Dec;62:103083. doi: 10.1016/j.ebiom.2020.103083
   PubMed Web of Science ®Google Scholar
• Jang W, Song JS. Non-invasive imaging methods to evaluate non-alcoholic fatty liver disease with fat quantification: a review. Diagnostics (Basel). 2023 May 25;13(11):1852. doi: 10.3390/diagnostics13111852
   PubMedGoogle Scholar
• Zeng KY, Bao WY, Wang YH, et al. Non-invasive evaluation of liver steatosis with imaging modalities: new techniques and applications. World J Gastroenterol. 2023 May 7;29(17):2534–2550. doi: 10.3748/wjg.v29.i17.2534
   PubMed Web of Science ®Google Scholar
• Theel W, Boxma-de Klerk BM, Dirksmeier-Harinck F, et al. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques. Obes Rev. 2022 Aug;23(8):e13481. doi: 10.1111/obr.13481
   PubMed Web of Science ®Google Scholar
• Nogami A, Yoneda M, Iwaki M, et al. Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future. Clin Mol Hepatol. 2023 Feb;29(Suppl):S123–s135. doi: 10.3350/cmh.2022.0357
   PubMedGoogle Scholar
• Lao TT. Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. Best Pract Res Clin Obstet Gynaecol. 2020 Oct;68:2–11. doi: 10.1016/j.bpobgyn.2020.02.011
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016 Apr;64(4):933–945. doi: 10.1016/j.jhep.2015.11.030
   PubMed Web of Science ®Google Scholar
• Dajti E, Bruni A, Barbara G, et al. Diagnostic approach to elevated liver function tests during pregnancy: a pragmatic narrative review. J Pers Med. 2023 Sep 16;13(9):1388. doi: 10.3390/jpm13091388
   PubMed Web of Science ®Google Scholar
• Elefsiniotis IS, Tsoumakas K, Kapritsou M, et al. Liver function tests in viremic and nonviremic chronic hepatitis B virus-infected pregnant women: importance of alanine aminotransferase/sodium ratio. Gastroenterol Nurs. 2013 Nov;36(6):422–428. doi: 10.1097/SGA.0000000000000004
   PubMed Web of Science ®Google Scholar
• Mei-Dan E, Wiznitzer A, Sergienko R, et al. Prediction of preeclampsia: liver function tests during the first 20 gestational weeks. J Matern Fetal Neonatal Med. 2013 Feb;26(3):250–253. doi: 10.3109/14767058.2012.733771
   PubMed Web of Science ®Google Scholar
• Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013 Nov;209(5):456.e1–7. doi: 10.1016/j.ajog.2013.07.006
   PubMed Web of Science ®Google Scholar
• Liu G, Shang X, Yuan B, et al. Acute fatty liver of pregnancy: analysis on the diagnosis and treatment of 15 cases. J Reprod Med. 2016 May;61(5–6):282–286.
   PubMed Web of Science ®Google Scholar
• Morisco F, Bruno R, Bugianesi E. AISF position paper on liver disease and pregnancy. Dig Liver Dis. 2016 Feb;48(2):120–137. doi: 10.1016/j.dld.2015.11.004
   PubMedGoogle Scholar
• Flemming JA, Mullin M, Lu J, et al. Outcomes of pregnant women with cirrhosis and their infants in a population-based study. Gastroenterology. 2020 Nov;159(5):1752–1762.e10. doi: 10.1053/j.gastro.2020.07.052
   PubMed Web of Science ®Google Scholar
• Sarkar M, Djerboua M, Flemming JA. NAFLD cirrhosis is rising among childbearing women and is the most common cause of cirrhosis in pregnancy. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e315–e318. doi: 10.1016/j.cgh.2021.01.022
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep;46(3):922–938. doi: 10.1002/hep.21907
   PubMed Web of Science ®Google Scholar
• Bertot LC, Jeffrey GP, Wallace M, et al. Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma. Hepatol Commun. 2017 Feb;1(1):53–60. doi: 10.1002/hep4.1018
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310–335. doi: 10.1002/hep.28906
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182–236. doi: 10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterol. 2011 Oct;141(4):1249–1253. doi: 10.1053/j.gastro.2011.06.061
   PubMed Web of Science ®Google Scholar
• Platner MH, Ackerman CM, Howland RE, et al. Severe maternal morbidity and mortality during delivery hospitalization of class I, II, III, and super obese women. Am J Obstet GynecolMFM. 2021 Sep;3(5):100420. doi: 10.1016/j.ajogmf.2021.100420
   Web of Science ®Google Scholar
• Durst JK, Tuuli MG, Stout MJ, et al. Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol. 2016 May;214(5):651.e1–5. doi: 10.1016/j.ajog.2015.11.024
   PubMed Web of Science ®Google Scholar
• Crane JM, Murphy P, Burrage L, et al. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can. 2013 Jul;35(7):606–611. doi: 10.1016/S1701-2163(15)30879-3
   PubMedGoogle Scholar
• Sarkar M, Brady CW, Fleckenstein J, et al. Reproductive health and liver disease: practice guidance by the American association for the study of liver diseases. Hepatology. 2021 Jan;73(1):318–365. doi: 10.1002/hep.31559
   PubMed Web of Science ®Google Scholar
• Hagström H, Höijer J, Ludvigsson JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2016 Feb;36(2):268–274. doi: 10.1111/liv.12902
   PubMed Web of Science ®Google Scholar
• Lee SM, Jung YM, Choi ES, et al. Metabolic dysfunction-associated fatty liver disease and subsequent development of adverse pregnancy outcomes. Clin Gastroenterol Hepatol. 2022 Nov;20(11):2542–2550.e8. doi: 10.1016/j.cgh.2021.11.007
   PubMed Web of Science ®Google Scholar
• El Jamaly H, Eslick GD, Weltman M. Systematic review with meta-analysis: non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clin Mol Hepatol. 2022 Jan;28(1):52–66. doi: 10.3350/cmh.2021.0205
   PubMed Web of Science ®Google Scholar
• Dyah AA, Rahadina R. Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis. Clin Exp Hepatol. 2021 Sep;7(3):305–311. doi: 10.5114/ceh.2021.109228
   PubMed Web of Science ®Google Scholar
• Koralegedara IS, Warnasekara JN, Dayaratne KG, et al. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages – prospective study in rajarata pregnancy cohort (RaPco). BMJ Open Gastroenterol. 2022 Feb;9(1):e000831. doi: 10.1136/bmjgast-2021-000831
   PubMed Web of Science ®Google Scholar
• Jung YM, Lee SM, Hong S, et al. The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. Liver Int. 2020 Oct;40(10):2417–2426. doi: 10.1111/liv.14563
   PubMed Web of Science ®Google Scholar
• Herath RP, Siriwardana SR, Ekanayake CD, et al. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: a cross sectional analytical study. PLoS One. 2019;14(4):e0215326. doi: 10.1371/journal.pone.0215326
   PubMed Web of Science ®Google Scholar
• LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Dec 2;161(11):819–826. doi: 10.7326/M14-1884
   PubMed Web of Science ®Google Scholar
• Vos MB. Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease. Hepatology. 2013 Jul;58(1):4–5. doi: 10.1002/hep.26389
   PubMed Web of Science ®Google Scholar
• Reynolds RM, Allan KM, Raja EA, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ. 2013 Aug 13;347(aug13 1):f4539. doi: 10.1136/bmj.f4539
   PubMedGoogle Scholar
• Glastras SJ, Chen H, Pollock CA, et al. Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. Biosci Rep. 2018 Apr 27;38(2). doi: 10.1042/BSR20180050
   PubMedGoogle Scholar
• Lagisz M, Blair H, Kenyon P, et al. Little appetite for obesity: meta-analysis of the effects of maternal obesogenic diets on offspring food intake and body mass in rodents. Int J Obes (Lond). 2015 Dec;39(12):1669–1678. doi: 10.1038/ijo.2015.160
   PubMed Web of Science ®Google Scholar
• Mouralidarane A, Soeda J, Visconti-Pugmire C, et al. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology. 2013 Jul;58(1):128–138. doi: 10.1002/hep.26248
   PubMed Web of Science ®Google Scholar
• Oben JA, Mouralidarane A, Samuelsson AM, et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol. 2010 Jun;52(6):913–920. doi: 10.1016/j.jhep.2009.12.042
   PubMed Web of Science ®Google Scholar
• Thompson MD. Developmental programming of NAFLD by parental obesity. Hepatol Commun. 2020 Oct;4(10):1392–1403. doi: 10.1002/hep4.1578
   PubMed Web of Science ®Google Scholar
• Ayonrinde OT, Oddy WH, Adams LA, et al. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. J Hepatol. 2017 Sep;67(3):568–576. doi: 10.1016/j.jhep.2017.03.029
   PubMed Web of Science ®Google Scholar
• Soullane S, Willems P, Lee GE, et al. Early life programming of nonalcoholic fatty liver disease in children. Early Hum Dev. 2022 May;168:105578. doi: 10.1016/j.earlhumdev.2022.105578
   PubMed Web of Science ®Google Scholar
• Patel S, Lawlor DA, Callaway M, et al. Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. BMC Pediatr. 2016 Mar 31;16(1):47. doi: 10.1186/s12887-016-0585-y
   PubMedGoogle Scholar
• Bellatorre A, Scherzinger A, Stamm E, et al. Fetal overnutrition and adolescent hepatic fat fraction: the exploring perinatal outcomes in children study. J Pediatr. 2018 Jan;192:165–170.e1. doi: 10.1016/j.jpeds.2017.09.008
   PubMed Web of Science ®Google Scholar
• Hagström H, Simon TG, Roelstraete B, et al. Maternal obesity increases the risk and severity of NAFLD in offspring. J Hepatol. 2021 Nov;75(5):1042–1048. doi: 10.1016/j.jhep.2021.06.045
   PubMed Web of Science ®Google Scholar